PF-Atlas › Clinical Trials › NCT01100606
A Study to Evaluate the Mode of Administration and Safety of EUR-1008 in Infants 1 to 12 Months of Age
EUR-1008 · Phase 4
Registry ID
NCT01100606
Phase
Phase 4
Status
Completed
Drug / intervention
EUR-1008 (APT-1008)
Sponsor
Forest Laboratories
Start
2010-06
About this trial
EUR-1008 is evaluated in NCT01100606, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Forest Laboratories. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT01100606 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.